eduKateSG · Why Science?
Measure how a medicine releases drug into a controlled liquid environment while keeping apparatus, medium, motion, time and sampling traceable
Read FDA’s final June 2011 Q4B Annex 7(R2) through pharmacopoeial interchangeability, apparatus 1 and 2, medium, deaeration, temperature, rotation, sampling, filtration, analysis, acceptance and lifecycle control.
A tablet looks still in a glass of liquid, yet its particles are wetting, breaking apart and releasing molecules. A dissolution test makes that changing process measurable under carefully controlled laboratory conditions.
FDA lists Q4B Annex 7(R2), Dissolution Test General Chapter, as final guidance dated June 2011. FDA says the annex is part of the Q4B series and is intended to support recognition of selected pharmacopoeial texts as interchangeable in ICH regions.
Did you know? Dissolution is not the same as disintegration. A dosage form can break into pieces without every drug molecule dissolving, so the two tests answer different quality questions.
For students, the test is a miniature lesson in transport science: agitation, temperature, surface area, solubility, diffusion and sampling all shape the measured curve.
Chapter index
Chapters 1–9: final June 2011 Q4B Annex 7(R2)
- 1. Annex 7(R2) owns the pharmacopoeial dissolution intent
- 2. FDA lists the annex as final guidance from June 2011
- 3. Dissolution measures release under defined in-vitro conditions
- 4. Apparatus choice shapes the hydrodynamic environment
- 5. Mechanical qualification protects comparability
- 6. The medium controls chemical opportunity to dissolve
- 7. Temperature is a controlled experimental variable
- 8. Deaeration can matter when bubbles change the test
- 9. Dosage-form placement starts the clock
Chapters 10–17: dissolution apparatus, medium, hydrodynamics, sampling, analysis, acceptance and change control
- 10. Rotation speed creates a reproducible challenge
- 11. Sampling location and timing protect the profile
- 12. Filtration is part of the analytical method
- 13. Quantitation needs a suitable analytical procedure
- 14. Acceptance uses staged rules or a registered criterion
- 15. Observations help explain unusual profiles
- 16. Changes require impact assessment
- 17. A complete Annex 7 receipt reconstructs the run
CHAPTER 1 OF 17 · Understand dissolution
1. Annex 7(R2) owns the pharmacopoeial dissolution intent
The annex evaluates selected dissolution-test general chapters and gives recommendations for their use in ICH regions. It does not create one product-wide dissolution specification or replace product-specific methods and acceptance criteria.
The scientific value of annex 7(r2) owns the pharmacopoeial dissolution intent becomes clear when a test result is connected to a defined quality decision. The annex evaluates selected dissolution-test general chapters and gives recommendations for their use in ICH regions. It does not create one product-wide dissolution specification or replace product-specific methods and acceptance criteria. Keep this boundary visible: An in-vitro dissolution result does not by itself predict clinical performance.
Try this
Build an evidence receipt for annex 7(r2) owns the pharmacopoeial dissolution intent. Trace annex 7(r2) owns the pharmacopoeial dissolution intent from vessel and dosage unit through sampling, analysis and acceptance. Add the document version, owner and acceptance rule. Keep this limit: An in-vitro dissolution result does not by itself predict clinical performance.
A strong science note separates observation from interpretation. Trace annex 7(r2) owns the pharmacopoeial dissolution intent from vessel and dosage unit through sampling, analysis and acceptance. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Trace annex 7(r2) owns the pharmacopoeial dissolution intent from vessel and dosage unit through sampling, analysis and acceptance. Keep this boundary visible: An in-vitro dissolution result does not by itself predict clinical performance.
CHAPTER 2 OF 17 · Understand dissolution
2. FDA lists the annex as final guidance from June 2011
The official FDA page identifies Q4B Annex 7(R2) as final and names CDER and CBER as issuing offices. It also states that Q4B implementation is intended to avoid redundant testing by industry.
For fda lists the annex as final guidance from june 2011, harmonisation works because laboratories can see both the shared method and the conditions attached to its use. The official FDA page identifies Q4B Annex 7(R2) as final and names CDER and CBER as issuing offices. It also states that Q4B implementation is intended to avoid redundant testing by industry. Preserve this guardrail: The product specification and registered method still govern the acceptance decision.
Try this
Challenge the assumptions behind fda lists the annex as final guidance from june 2011. Challenge apparatus, medium, timing and filtration assumptions behind fda lists the annex as final guidance from june 2011. Test one plausible failure mode and record what changes. Respect this boundary: The product specification and registered method still govern the acceptance decision.
A strong science note separates observation from interpretation. Challenge apparatus, medium, timing and filtration assumptions behind fda lists the annex as final guidance from june 2011. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Challenge apparatus, medium, timing and filtration assumptions behind fda lists the annex as final guidance from june 2011. Keep this boundary visible: The product specification and registered method still govern the acceptance decision.
CHAPTER 3 OF 17 · Understand dissolution
3. Dissolution measures release under defined in-vitro conditions
A vessel holds medium at controlled temperature while a rotating basket or paddle creates repeatable motion. Samples taken over time are analysed for dissolved drug. The result describes performance in the test, not a complete simulation of a human body.
A trustworthy account of dissolution measures release under defined in-vitro conditions keeps the material, apparatus, procedure, calculation and decision together. A vessel holds medium at controlled temperature while a rotating basket or paddle creates repeatable motion. Samples taken over time are analysed for dissolved drug. The result describes performance in the test, not a complete simulation of a human body. Remember: Hydrodynamics can change when apparatus geometry, alignment or speed changes.
Try this
Audit the laboratory route for dissolution measures release under defined in-vitro conditions. Recalculate dissolution measures release under defined in-vitro conditions using actual sample times, replacement volumes and standard potency. Mark every handoff where identity, timing or units could be lost. Preserve this caution: Hydrodynamics can change when apparatus geometry, alignment or speed changes.
A strong science note separates observation from interpretation. Recalculate dissolution measures release under defined in-vitro conditions using actual sample times, replacement volumes and standard potency. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Recalculate dissolution measures release under defined in-vitro conditions using actual sample times, replacement volumes and standard potency. Keep this boundary visible: Hydrodynamics can change when apparatus geometry, alignment or speed changes.
CHAPTER 4 OF 17 · Understand dissolution
4. Apparatus choice shapes the hydrodynamic environment
Basket apparatus 1 and paddle apparatus 2 create different flow patterns and interactions with the dosage form. The registered method specifies apparatus, dimensions, alignment and speed. Switching apparatus changes the experiment.
The scientific value of apparatus choice shapes the hydrodynamic environment becomes clear when a test result is connected to a defined quality decision. Basket apparatus 1 and paddle apparatus 2 create different flow patterns and interactions with the dosage form. The registered method specifies apparatus, dimensions, alignment and speed. Switching apparatus changes the experiment. Keep this boundary visible: A sample can keep changing after withdrawal unless filtration and timing are controlled.
Try this
Build an evidence receipt for apparatus choice shapes the hydrodynamic environment. Reassess apparatus choice shapes the hydrodynamic environment after a formulation, process, equipment or storage change. Add the document version, owner and acceptance rule. Keep this limit: A sample can keep changing after withdrawal unless filtration and timing are controlled.
A strong science note separates observation from interpretation. Reassess apparatus choice shapes the hydrodynamic environment after a formulation, process, equipment or storage change. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Reassess apparatus choice shapes the hydrodynamic environment after a formulation, process, equipment or storage change. Keep this boundary visible: A sample can keep changing after withdrawal unless filtration and timing are controlled.
CHAPTER 5 OF 17 · Control the apparatus
5. Mechanical qualification protects comparability
Shaft centring, verticality, wobble, vessel geometry, basket or paddle condition and rotational speed can influence fluid flow. Installation, operational checks and maintenance records connect an apparently simple instrument to measurement confidence.
For mechanical qualification protects comparability, harmonisation works because laboratories can see both the shared method and the conditions attached to its use. Shaft centring, verticality, wobble, vessel geometry, basket or paddle condition and rotational speed can influence fluid flow. Installation, operational checks and maintenance records connect an apparently simple instrument to measurement confidence. Preserve this guardrail: An in-vitro dissolution result does not by itself predict clinical performance.
Try this
Challenge the assumptions behind mechanical qualification protects comparability. Trace mechanical qualification protects comparability from vessel and dosage unit through sampling, analysis and acceptance. Test one plausible failure mode and record what changes. Respect this boundary: An in-vitro dissolution result does not by itself predict clinical performance.
A strong science note separates observation from interpretation. Trace mechanical qualification protects comparability from vessel and dosage unit through sampling, analysis and acceptance. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Trace mechanical qualification protects comparability from vessel and dosage unit through sampling, analysis and acceptance. Keep this boundary visible: An in-vitro dissolution result does not by itself predict clinical performance.
CHAPTER 6 OF 17 · Control the apparatus
6. The medium controls chemical opportunity to dissolve
Composition, pH, ionic strength, surfactant, volume and preparation can change solubility and wetting. Reagents, water quality and preparation timing are documented. A medium selected for one product should not be assumed suitable for another.
A trustworthy account of the medium controls chemical opportunity to dissolve keeps the material, apparatus, procedure, calculation and decision together. Composition, pH, ionic strength, surfactant, volume and preparation can change solubility and wetting. Reagents, water quality and preparation timing are documented. A medium selected for one product should not be assumed suitable for another. Remember: The product specification and registered method still govern the acceptance decision.
Try this
Audit the laboratory route for the medium controls chemical opportunity to dissolve. Challenge apparatus, medium, timing and filtration assumptions behind the medium controls chemical opportunity to dissolve. Mark every handoff where identity, timing or units could be lost. Preserve this caution: The product specification and registered method still govern the acceptance decision.
A strong science note separates observation from interpretation. Challenge apparatus, medium, timing and filtration assumptions behind the medium controls chemical opportunity to dissolve. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Challenge apparatus, medium, timing and filtration assumptions behind the medium controls chemical opportunity to dissolve. Keep this boundary visible: The product specification and registered method still govern the acceptance decision.
CHAPTER 7 OF 17 · Control the apparatus
7. Temperature is a controlled experimental variable
The medium is maintained at the specified temperature throughout the run, with qualified measurement and defined tolerances. Temperature affects solubility, viscosity and diffusion, so the record includes actual readings rather than a set point alone.
The scientific value of temperature is a controlled experimental variable becomes clear when a test result is connected to a defined quality decision. The medium is maintained at the specified temperature throughout the run, with qualified measurement and defined tolerances. Temperature affects solubility, viscosity and diffusion, so the record includes actual readings rather than a set point alone. Keep this boundary visible: Hydrodynamics can change when apparatus geometry, alignment or speed changes.
Try this
Build an evidence receipt for temperature is a controlled experimental variable. Recalculate temperature is a controlled experimental variable using actual sample times, replacement volumes and standard potency. Add the document version, owner and acceptance rule. Keep this limit: Hydrodynamics can change when apparatus geometry, alignment or speed changes.
A strong science note separates observation from interpretation. Recalculate temperature is a controlled experimental variable using actual sample times, replacement volumes and standard potency. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Recalculate temperature is a controlled experimental variable using actual sample times, replacement volumes and standard potency. Keep this boundary visible: Hydrodynamics can change when apparatus geometry, alignment or speed changes.
CHAPTER 8 OF 17 · Control the apparatus
8. Deaeration can matter when bubbles change the test
Dissolved gases may form bubbles on the dosage form or apparatus and alter contact or flow. When required by the method, deaeration procedure, hold time and handling are controlled. Unnecessary or inconsistent deaeration can add variability.
For deaeration can matter when bubbles change the test, harmonisation works because laboratories can see both the shared method and the conditions attached to its use. Dissolved gases may form bubbles on the dosage form or apparatus and alter contact or flow. When required by the method, deaeration procedure, hold time and handling are controlled. Unnecessary or inconsistent deaeration can add variability. Preserve this guardrail: A sample can keep changing after withdrawal unless filtration and timing are controlled.
Try this
Challenge the assumptions behind deaeration can matter when bubbles change the test. Reassess deaeration can matter when bubbles change the test after a formulation, process, equipment or storage change. Test one plausible failure mode and record what changes. Respect this boundary: A sample can keep changing after withdrawal unless filtration and timing are controlled.
A strong science note separates observation from interpretation. Reassess deaeration can matter when bubbles change the test after a formulation, process, equipment or storage change. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Reassess deaeration can matter when bubbles change the test after a formulation, process, equipment or storage change. Keep this boundary visible: A sample can keep changing after withdrawal unless filtration and timing are controlled.
The unit is introduced without trapping it in an unintended location or damaging it. Sinkers, if specified, have a defined design. Start time, vessel identity and observations such as floating, coning or sticking belong in the raw record.
A trustworthy account of dosage-form placement starts the clock keeps the material, apparatus, procedure, calculation and decision together. The unit is introduced without trapping it in an unintended location or damaging it. Sinkers, if specified, have a defined design. Start time, vessel identity and observations such as floating, coning or sticking belong in the raw record. Remember: An in-vitro dissolution result does not by itself predict clinical performance.
Try this
Audit the laboratory route for dosage-form placement starts the clock. Trace dosage-form placement starts the clock from vessel and dosage unit through sampling, analysis and acceptance. Mark every handoff where identity, timing or units could be lost. Preserve this caution: An in-vitro dissolution result does not by itself predict clinical performance.
A strong science note separates observation from interpretation. Trace dosage-form placement starts the clock from vessel and dosage unit through sampling, analysis and acceptance. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Trace dosage-form placement starts the clock from vessel and dosage unit through sampling, analysis and acceptance. Keep this boundary visible: An in-vitro dissolution result does not by itself predict clinical performance.
CHAPTER 10 OF 17 · Protect the sample
10. Rotation speed creates a reproducible challenge
Revolutions per minute are set, verified and recorded. Even within tolerance, vibration, vessel differences or shaft condition can influence flow. Changing speed to make a difficult result pass would invalidate the predefined comparison.
The scientific value of rotation speed creates a reproducible challenge becomes clear when a test result is connected to a defined quality decision. Revolutions per minute are set, verified and recorded. Even within tolerance, vibration, vessel differences or shaft condition can influence flow. Changing speed to make a difficult result pass would invalidate the predefined comparison. Keep this boundary visible: The product specification and registered method still govern the acceptance decision.
Try this
Build an evidence receipt for rotation speed creates a reproducible challenge. Challenge apparatus, medium, timing and filtration assumptions behind rotation speed creates a reproducible challenge. Add the document version, owner and acceptance rule. Keep this limit: The product specification and registered method still govern the acceptance decision.
A strong science note separates observation from interpretation. Challenge apparatus, medium, timing and filtration assumptions behind rotation speed creates a reproducible challenge. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Challenge apparatus, medium, timing and filtration assumptions behind rotation speed creates a reproducible challenge. Keep this boundary visible: The product specification and registered method still govern the acceptance decision.
CHAPTER 11 OF 17 · Protect the sample
11. Sampling location and timing protect the profile
Samples are withdrawn from the specified zone at actual recorded times without disturbing the vessel. Replacement medium and volume correction follow the method. A few seconds may matter near a steep early release phase.
For sampling location and timing protect the profile, harmonisation works because laboratories can see both the shared method and the conditions attached to its use. Samples are withdrawn from the specified zone at actual recorded times without disturbing the vessel. Replacement medium and volume correction follow the method. A few seconds may matter near a steep early release phase. Preserve this guardrail: Hydrodynamics can change when apparatus geometry, alignment or speed changes.
Try this
Challenge the assumptions behind sampling location and timing protect the profile. Recalculate sampling location and timing protect the profile using actual sample times, replacement volumes and standard potency. Test one plausible failure mode and record what changes. Respect this boundary: Hydrodynamics can change when apparatus geometry, alignment or speed changes.
A strong science note separates observation from interpretation. Recalculate sampling location and timing protect the profile using actual sample times, replacement volumes and standard potency. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Recalculate sampling location and timing protect the profile using actual sample times, replacement volumes and standard potency. Keep this boundary visible: Hydrodynamics can change when apparatus geometry, alignment or speed changes.
CHAPTER 12 OF 17 · Protect the sample
12. Filtration is part of the analytical method
A filter should stop undissolved particles without adsorbing analyte or releasing interference. Filter material, pore size, discard volume and hold time are evaluated. Centrifugation or delayed filtration can permit continued dissolution after sampling.
A trustworthy account of filtration is part of the analytical method keeps the material, apparatus, procedure, calculation and decision together. A filter should stop undissolved particles without adsorbing analyte or releasing interference. Filter material, pore size, discard volume and hold time are evaluated. Centrifugation or delayed filtration can permit continued dissolution after sampling. Remember: A sample can keep changing after withdrawal unless filtration and timing are controlled.
Try this
Audit the laboratory route for filtration is part of the analytical method. Reassess filtration is part of the analytical method after a formulation, process, equipment or storage change. Mark every handoff where identity, timing or units could be lost. Preserve this caution: A sample can keep changing after withdrawal unless filtration and timing are controlled.
A strong science note separates observation from interpretation. Reassess filtration is part of the analytical method after a formulation, process, equipment or storage change. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Reassess filtration is part of the analytical method after a formulation, process, equipment or storage change. Keep this boundary visible: A sample can keep changing after withdrawal unless filtration and timing are controlled.
CHAPTER 13 OF 17 · Interpret the profile
13. Quantitation needs a suitable analytical procedure
UV or chromatographic measurement requires specificity, range, calibration and solution stability appropriate to the medium and expected concentration. Instrument response, dilution and standard potency calculations remain traceable to each vessel.
The scientific value of quantitation needs a suitable analytical procedure becomes clear when a test result is connected to a defined quality decision. UV or chromatographic measurement requires specificity, range, calibration and solution stability appropriate to the medium and expected concentration. Instrument response, dilution and standard potency calculations remain traceable to each vessel. Keep this boundary visible: An in-vitro dissolution result does not by itself predict clinical performance.
Try this
Build an evidence receipt for quantitation needs a suitable analytical procedure. Trace quantitation needs a suitable analytical procedure from vessel and dosage unit through sampling, analysis and acceptance. Add the document version, owner and acceptance rule. Keep this limit: An in-vitro dissolution result does not by itself predict clinical performance.
A strong science note separates observation from interpretation. Trace quantitation needs a suitable analytical procedure from vessel and dosage unit through sampling, analysis and acceptance. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Trace quantitation needs a suitable analytical procedure from vessel and dosage unit through sampling, analysis and acceptance. Keep this boundary visible: An in-vitro dissolution result does not by itself predict clinical performance.
CHAPTER 14 OF 17 · Interpret the profile
14. Acceptance uses staged rules or a registered criterion
The pharmacopoeial chapter and product specification define how individual units and stages are assessed. The Q value, number of units and decision rule are not interchangeable with an average alone; one mean can hide unacceptable individual behaviour.
For acceptance uses staged rules or a registered criterion, harmonisation works because laboratories can see both the shared method and the conditions attached to its use. The pharmacopoeial chapter and product specification define how individual units and stages are assessed. The Q value, number of units and decision rule are not interchangeable with an average alone; one mean can hide unacceptable individual behaviour. Preserve this guardrail: The product specification and registered method still govern the acceptance decision.
Try this
Challenge the assumptions behind acceptance uses staged rules or a registered criterion. Challenge apparatus, medium, timing and filtration assumptions behind acceptance uses staged rules or a registered criterion. Test one plausible failure mode and record what changes. Respect this boundary: The product specification and registered method still govern the acceptance decision.
A strong science note separates observation from interpretation. Challenge apparatus, medium, timing and filtration assumptions behind acceptance uses staged rules or a registered criterion. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Challenge apparatus, medium, timing and filtration assumptions behind acceptance uses staged rules or a registered criterion. Keep this boundary visible: The product specification and registered method still govern the acceptance decision.
CHAPTER 15 OF 17 · Interpret the profile
15. Observations help explain unusual profiles
Coning, air bubbles, cross-linking, capsule shells, sticking, fragments and vessel asymmetry can reveal why units differ. Observations support investigation but do not permit an analyst to discard results without a scientifically justified, documented cause.
A trustworthy account of observations help explain unusual profiles keeps the material, apparatus, procedure, calculation and decision together. Coning, air bubbles, cross-linking, capsule shells, sticking, fragments and vessel asymmetry can reveal why units differ. Observations support investigation but do not permit an analyst to discard results without a scientifically justified, documented cause. Remember: Hydrodynamics can change when apparatus geometry, alignment or speed changes.
Try this
Audit the laboratory route for observations help explain unusual profiles. Recalculate observations help explain unusual profiles using actual sample times, replacement volumes and standard potency. Mark every handoff where identity, timing or units could be lost. Preserve this caution: Hydrodynamics can change when apparatus geometry, alignment or speed changes.
A strong science note separates observation from interpretation. Recalculate observations help explain unusual profiles using actual sample times, replacement volumes and standard potency. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Recalculate observations help explain unusual profiles using actual sample times, replacement volumes and standard potency. Keep this boundary visible: Hydrodynamics can change when apparatus geometry, alignment or speed changes.
Formulation, particle size, process, scale, equipment, site, packaging or storage can alter dissolution. Change control considers the registered method, comparability, stability and regulatory reporting rather than assuming a passing release test closes every question.
The scientific value of changes require impact assessment becomes clear when a test result is connected to a defined quality decision. Formulation, particle size, process, scale, equipment, site, packaging or storage can alter dissolution. Change control considers the registered method, comparability, stability and regulatory reporting rather than assuming a passing release test closes every question. Keep this boundary visible: A sample can keep changing after withdrawal unless filtration and timing are controlled.
Try this
Build an evidence receipt for changes require impact assessment. Reassess changes require impact assessment after a formulation, process, equipment or storage change. Add the document version, owner and acceptance rule. Keep this limit: A sample can keep changing after withdrawal unless filtration and timing are controlled.
A strong science note separates observation from interpretation. Reassess changes require impact assessment after a formulation, process, equipment or storage change. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Reassess changes require impact assessment after a formulation, process, equipment or storage change. Keep this boundary visible: A sample can keep changing after withdrawal unless filtration and timing are controlled.
CHAPTER 17 OF 17 · Interpret the profile
17. A complete Annex 7 receipt reconstructs the run
The record includes annex and pharmacopoeial versions, product and batch, unit identity, apparatus, equipment qualification, vessels, medium lot and preparation, temperature, speed, sinker, actual sample times, replacement volumes, filter study, analytical sequence, calculations, observations, acceptance, deviations and review.
For a complete annex 7 receipt reconstructs the run, harmonisation works because laboratories can see both the shared method and the conditions attached to its use. The record includes annex and pharmacopoeial versions, product and batch, unit identity, apparatus, equipment qualification, vessels, medium lot and preparation, temperature, speed, sinker, actual sample times, replacement volumes, filter study, analytical sequence, calculations, observations, acceptance, deviations and review. Preserve this guardrail: An in-vitro dissolution result does not by itself predict clinical performance.
Try this
Challenge the assumptions behind a complete annex 7 receipt reconstructs the run. Trace a complete annex 7 receipt reconstructs the run from vessel and dosage unit through sampling, analysis and acceptance. Test one plausible failure mode and record what changes. Respect this boundary: An in-vitro dissolution result does not by itself predict clinical performance.
A strong science note separates observation from interpretation. Trace a complete annex 7 receipt reconstructs the run from vessel and dosage unit through sampling, analysis and acceptance. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Trace a complete annex 7 receipt reconstructs the run from vessel and dosage unit through sampling, analysis and acceptance. Keep this boundary visible: An in-vitro dissolution result does not by itself predict clinical performance.
Dissolution evidence map
| Question | Evidence to capture | Boundary to retain |
|---|---|---|
| What releases? | Defined dosage form, strength and batch | Preserve identity |
| Under what challenge? | Apparatus, medium, temperature and rotation | Control hydrodynamics |
| How is it measured? | Timed sampling, filtration and quantitation | Keep the sample stable |
| How is it judged? | Individual-unit rules and registered acceptance | Use the correct criterion |
Science learning becomes useful when a student can show where a claim came from, why it applies and where it stops. Continue with the eduKate Science Learning Hub, compare choices in the Education Hub, and connect these habits to career pathways built from subject capabilities.
Dissolution testing turns a moving physical process into a reviewable quality result. When the vessel, liquid, motion, clock and analysis remain aligned, the curve becomes useful evidence rather than a pretty line on a chart.
Primary sources and verification date
Source status checked 26 October 2026. FDA guidance describes the agency’s current thinking and does not replace applicable statutes, regulations or product-specific communication with FDA.
- FDA: Q4B Annex 7(R2) Dissolution Test General Chapter — Final guidance, June 2011; checked 26 October 2026.
- ICH: Quality Guidelines — Official Q4B annex index and harmonisation context.
- FDA: Dissolution Testing of Immediate Release Solid Oral Dosage Forms — FDA product-development context for dissolution; not a substitute for Annex 7.